Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Return on Assets (2016 - 2025)

Fate Therapeutics (FATE) has disclosed Return on Assets for 13 consecutive years, with 0.41% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets changed 0.0% year-over-year to 0.41%, compared with a TTM value of 0.41% through Dec 2025, changed 0.0%, and an annual FY2025 reading of 0.36%, up 5.0% over the prior year.
  • Return on Assets was 0.41% for Q4 2025 at Fate Therapeutics, up from 0.45% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.15% in Q2 2021 and bottomed at 0.46% in Q2 2025.
  • Average Return on Assets over 5 years is 0.34%, with a median of 0.36% recorded in 2024.
  • The sharpest move saw Return on Assets rose 19bps in 2021, then dropped -22bps in 2022.
  • Year by year, Return on Assets stood at 0.23% in 2021, then crashed by -84bps to 0.42% in 2022, then increased by 21bps to 0.33% in 2023, then fell by -25bps to 0.41% in 2024, then grew by 0bps to 0.41% in 2025.
  • Business Quant data shows Return on Assets for FATE at 0.41% in Q4 2025, 0.45% in Q3 2025, and 0.46% in Q2 2025.